Protocol summary
-
Study aim
-
Evaluation the effectiveness and comparing of True and Sham Thread Embedding in acupoints on Spasticity in Multiple Sclerosis
-
Design
-
A concealed, block randomized, double-blinded, 3rd phase of sham controlled clinical trial with a parallel group design of 38 patients
-
Settings and conduct
-
Patients referred to the neurology clinic of Mashhad Qaem Hospital, suffering from MS, according to the inclusion criteria and the approval of the MS fellowship, are referred to the acupuncture clinic of Imam Reza hospital. After signing the informed consent form, first evaluations are performed. In addition to the routine neurological treatment, the participants are placed in two groups and 30 acupoints are intervented. In True Embedding intervention group, after disinfection, 2cm PDO threads are embedded in the acupoints by a 20 gauge needle. In the Sham control group, the needle is inserted in the same points for blinding, but the thread is not embedded in the tissue. To prevent infection, cephalexin and to control pain, cold compress or Ibuprofen are prescribed. After 4 and 12 weeks, the outcomes are evaluated.
-
Participants/Inclusion and exclusion criteria
-
Inclusion Criteria: Definite diagnosis of MS; EDSS<7; Age>18; Resistant spasticity; Signing informed consent. Non-Inclusion Criteria: Receiving acupuncture in the last 6 months; Relapse or changing maintenance treatment in the last 2 months; Severe chronic systemic disease, cancers and coagulopathy; Sensitivity to Cephalosporins or thread; Pregnancy, Breastfeeding or uncertain contraception
-
Intervention groups
-
Intervention group: True Embedding of Polydioxanone Threads in 30 Acupoints. Sham control group: Needling in 30 Acupoints Without inserting Threads
-
Main outcome variables
-
Disability, Spasm, Walking quality, Daily life activities, Pain, Fatigue, Sleep, Urinary symptoms, Depression, Anxiety and Quality of life score
General information
-
Reason for update
-
Expected recruitment end date and the McDonald's criteria 2024 were updated.
-
Acronym
-
-
IRCT registration information
-
IRCT registration number:
IRCT20121228011912N8
Registration date:
2024-03-22, 1403/01/03
Registration timing:
prospective
Last update:
2026-07-13, 1405/04/22
Update count:
2
-
Registration date
-
2024-03-22, 1403/01/03
-
Registrant information
-
-
Recruitment status
-
Recruitment complete
-
Funding source
-
-
Expected recruitment start date
-
2024-04-03, 1403/01/15
-
Expected recruitment end date
-
2026-09-22, 1405/06/31
-
Actual recruitment start date
-
empty
-
Actual recruitment end date
-
empty
-
Trial completion date
-
empty
-
Scientific title
-
Comparison of the Effectiveness of True and Sham Thread Embedding Acupuncture on Spasticity in Multiple Sclerosis Patients
-
Public title
-
Effect of Thread Embedding Acupuncture on Spasticity of M.S
-
Purpose
-
Supportive
-
Inclusion/Exclusion criteria
-
Inclusion criteria:
Definitive diagnosis of MS based on McDonald's 2024 criteria by a neurologist
EDSS<7
Moderate to severe spasticity reported by the patient as NRS score≥4 with poor response to usual antispasmodics
Willingness to participate in the study and sign informed consent
Not taking anticoagulants
No history of any coagulopathy
No history of acupuncture in the last 6 months
No history of relapse phase in the last 2 months
No change in maintenance treatments during the last 2 months
No history of sensivity to cephalosporins
No history of sensivity to each components of the thread
No history of incurable chronic systemic diseases and cancers
Not being pregnant or breastfeeding and using a safe contraceptive method
Exclusion criteria:
Imbalance to continue cooperation with the study
Incidence of sensivity reaction to the embedded thread
Incidence of resistant bleeding requires medicinal intervention
Incidence of the relapse phase requires receiving a medicinal pulse
-
Age
-
From 18 years old
-
Gender
-
Both
-
Phase
-
3
-
Groups that have been masked
-
- Participant
- Data analyser
-
Sample size
-
Target sample size:
38
-
Randomization (investigator's opinion)
-
Randomized
-
Randomization description
-
Using the online site www.sealedenvelope.com, random allocation is done in two groups A (intervention) and group B (control). Block Randomization will be done with block sizes of 4 and 6 for random allocation. The prepared blocks will be placed inside the envelope. One of the envelopes will be randomly selected according to the order of patients' arrival, and patients will be assigned to groups.
Allocation concealment is done using sealed opaque envelopes. By one of the team members, random numbers will be prepared and placed inside the envelope. The envelopes will be closed and their contents will not be visible from the outside.
First, the purpose of the study is explained to the person with entry requirement critrias. Then, the person signs the informed consent form and one envelope will be taken and opened and patient will be entered into one of the two groups.
-
Blinding (investigator's opinion)
-
Double blinded
-
Blinding description
-
In this study, the intervention group is True embedding group and the Sham group is designed as a control group, and the participants are thus blinded.
The statistical analyst evaluates the information based on group A and B and is blinded to which group is belongs to A or B.
-
Placebo
-
Used
-
Assignment
-
Parallel
-
Other design features
-
The control group in acupuncture studies is called sham. Embedding studies are limited and the use of sham is not common in them. In this study, the sham is designed in such a way that all the embedding steps are performed, but the thread is not placed in the body tissue.
Ethics committees
1
-
Ethics committee
-
-
Approval date
-
2024-03-09, 1402/12/19
-
Ethics committee reference number
-
IR.MUMS.REC.1402.345
Health conditions studied
1
-
Description of health condition studied
-
Multiple sclerosis (M.S)
-
ICD-10 code
-
G35
-
ICD-10 code description
-
Multiple sclerosis
Primary outcomes
1
-
Description
-
Disability Status Score
-
Timepoint
-
Before intervention and 4 and 12 weeks after intervention
-
Method of measurement
-
Expanded Disability Status Scale (EDSS)
2
-
Description
-
Spasticity Score
-
Timepoint
-
Before intervention and 4 and 12 weeks after intervention
-
Method of measurement
-
Numerical Rating Scale (NRS)
3
-
Description
-
Quality of Walking Score
-
Timepoint
-
Before intervention and 4 and 12 weeks after intervention
-
Method of measurement
-
Multiple Sclerosis Walking Scale-12 (MSWS-12)
4
-
Description
-
Activities of Daily Living (ADL) Score
-
Timepoint
-
Before intervention and 4 and 12 weeks after intervention
-
Method of measurement
-
Barthel Index
5
-
Description
-
Pain Score
-
Timepoint
-
Before intervention and 4 and 12 weeks after intervention
-
Method of measurement
-
McGill pain questionnaire
Secondary outcomes
1
-
Description
-
Fatigue Score
-
Timepoint
-
Before intervention and 4 and 12 weeks after intervention
-
Method of measurement
-
Modified Fatigue Impact Scale (MFIS) questionnaire
2
-
Description
-
Quality of Sleep score
-
Timepoint
-
Before intervention and 4 and 12 weeks after intervention
-
Method of measurement
-
Pittsburgh Sleep Quality Index (PSQI-P)
3
-
Description
-
Urinary Symptoms Score
-
Timepoint
-
Before intervention and 4 and 12 weeks after intervention
-
Method of measurement
-
Actionable Bladder Symptom Screening Tool (ABSST)
4
-
Description
-
Depression Score
-
Timepoint
-
Before intervention and 4 and 12 weeks after intervention
-
Method of measurement
-
Hospital Anxiety and Depression Scale (HADS) questionnaire
5
-
Description
-
Quality of Life Score
-
Timepoint
-
Before intervention and 4 and 12 weeks after intervention
-
Method of measurement
-
EuroQoL Quality of Life questionnaire
6
-
Description
-
Intervention Satisfaction Score
-
Timepoint
-
Before intervention and 4 and 12 weeks after intervention
-
Method of measurement
-
Scoring (1-10) for satisfaction with the treatment outcomes, willingness to repeat the treatment, and recommendation to other patients
Intervention groups
1
-
Description
-
Intervention group: True 2cm Polydioxanon Thread Embedding Acupuncture in 30 acupoints (GV14, GV20, CV4, CV12, BL18, BL20, BL23, SP6, SP9, ST36, KI3, GB20, GB34, LI11 , LR3, LI4, BL57) in one session after disinfection
-
Category
-
Rehabilitation
2
-
Description
-
Control group: Sham group, Needling of 30 acupoints mentioned above without embedded thread in one session
-
Category
-
Placebo
1
-
Sponsor
-
-
Grant name
-
-
Grant code / Reference number
-
-
Is the source of funding the same sponsor organization/entity?
-
Yes
-
Title of funding source
-
Mashhad University of Medical Sciences
-
Proportion provided by this source
-
100
-
Public or private sector
-
Public
-
Domestic or foreign origin
-
Domestic
-
Category of foreign source of funding
-
empty
-
Country of origin
-
-
Type of organization providing the funding
-
Academic
Sharing plan
-
Deidentified Individual Participant Data Set (IPD)
-
Undecided - It is not yet known if there will be a plan to make this available
-
Study Protocol
-
Undecided - It is not yet known if there will be a plan to make this available
-
Statistical Analysis Plan
-
Undecided - It is not yet known if there will be a plan to make this available
-
Informed Consent Form
-
Undecided - It is not yet known if there will be a plan to make this available
-
Clinical Study Report
-
Undecided - It is not yet known if there will be a plan to make this available
-
Analytic Code
-
Undecided - It is not yet known if there will be a plan to make this available
-
Data Dictionary
-
Undecided - It is not yet known if there will be a plan to make this available